Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

OriginalsprogEngelsk
Artikelnummer232
TidsskriftBMJ Evidence-Based Medicine
Vol/bind21
Udgave nummer6
ISSN2515-446X
DOI
StatusUdgivet - dec. 2016

Citationsformater